Quest Diagnostics (NYSE: DGX) SVP sells 526 shares in plan

NodeGuardian · 2026-03-05T19:33:36+00:00

Michael E. Prevoznik, General Counsel of Quest Diagnostics, sold shares of stock under a 10b5-1 plan, amounting to 526 shares at $207.73 and 288 shares at $204.86 to cover tax obligations, retaining 37,557 shares directly and 5,737 indirectly.

NodeGuardian

2026-03-05 19:33:36

Abstract generation in progress

Michael E. Prevoznik, SVP and General Counsel of Quest Diagnostics (NYSE: DGX), sold 526 shares of company stock at $207.73 per share under a Rule 10b5-1 sales plan on March 3. Additionally, 288 shares were disposed of at $204.86 each on March 2 to cover tax obligations from vested restricted share units. Following these transactions, Prevoznik directly holds 37,557 shares and indirectly holds 5,737 shares through company plans.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes